Mesenchymal migration as a therapeutic target in glioblastoma

Jessie Zhong1, Andre Paul, Stewart J Kellie

  • 1Children's Cancer Research Unit, Kids Research Institute, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia.

Journal of Oncology
|July 24, 2010
PubMed

Insights

Glioblastoma cells invade brain tissue extensively, making surgical removal difficult and limiting treatment effectiveness. Targeting cell migration pathways offers a promising strategy to improve survival for these lethal brain tumors.

Area of Science:

  • Neuro-oncology
  • Cellular Biology
  • Cancer Research

Background:

  • Glioblastomas are aggressive brain tumors characterized by extensive infiltration of healthy brain tissue.
  • This deep infiltration complicates surgical resection and contributes to poor patient outcomes despite current therapies.
  • Resistance to radiation and chemotherapy further exacerbates the challenge of treating glioblastomas.

Purpose of the Study:

  • To investigate the role of adhesion signaling molecules and the actin cytoskeleton in glioblastoma cell invasion.
  • To review existing therapeutic strategies targeting glioblastoma cell migration.
  • To explore novel approaches for treating infiltrating glioblastomas.

Main Methods:

  • Focus on the mesenchymal mode of motility in invading glioblastoma cells.
  • Review of current therapeutic targets related to cell adhesion and cytoskeleton dynamics.
  • Discussion of cell migration mechanisms relevant to glioblastoma treatment.

Main Results:

  • Adhesion signaling and the actin cytoskeleton are critical for the invasive behavior of glioblastoma cells.
  • Targeting these cellular components presents a viable therapeutic avenue.
  • Understanding glioblastoma cell migration is key to developing more effective treatments.

Conclusions:

  • Targeting glioblastoma cell invasion mechanisms, particularly adhesion and cytoskeleton dynamics, holds significant promise for improving patient survival.
  • Further research into cell migration pathways could lead to novel therapeutic strategies.
  • Developing treatments that specifically address deep brain tumor infiltration is crucial for advancing glioblastoma patient care.